VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
TIDES Weekly: Oral Semaglutide EMA Recommendation & Multiple Oligonucleotide Therapies Show Positive Progress in Hepatitis B
TIDES Weekly: Oral Semaglutide EMA Recommendation & Multiple Oligonucleotide Therapies Show Positive Progress in Hepatitis B
May 31, 2026 07:30 CST Updated 09:55
Share:
GSK
Pharmaceutical R&D Manufacturer
Ionis Pharmaceuticals
RNA Drug Developer